{"meshTags":["Male","Adult","Mutation","Aged","Middle Aged","DNA Mutational Analysis","Adenocarcinoma","Receptor, Epidermal Growth Factor","Immunoenzyme Techniques","Stomach Neoplasms","Polymerase Chain Reaction","Humans","Aged, 80 and over","Female"],"meshMinor":["Male","Adult","Mutation","Aged","Middle Aged","DNA Mutational Analysis","Adenocarcinoma","Receptor, Epidermal Growth Factor","Immunoenzyme Techniques","Stomach Neoplasms","Polymerase Chain Reaction","Humans","Aged, 80 and over","Female"],"genes":["Epidermal growth factor receptor","EGFR","epidermal growth factor receptor","EGFR","anti-EGFR","EGFR gene","EGFR protein","EGFR gene","EGFR","EGFR gene","EGFR protein"],"publicationTypes":["Journal Article"],"abstract":"Since specific epidermal growth factor receptor (EGFR) somatic mutations have been demonstrated to influence the response to anti-EGFR therapy in non-small cell lung cancer, EGFR gene mutational analysis of different types of neoplasm is under investigation.\nEGFR protein expression and gene mutations in exons 18, 19 and 21 were investigated in 49 gastric adenocarcinomas.\nno specific EGFR gene mutations were detected, while EGFR positive staining was detected in 6% of the cases.\nOur findings indicate that in gastric adenocarcinoma, specific EGFR gene mutations are very rare or absent and the rate of EGFR protein expression is low.","title":"Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer.","pubmedId":"17094480"}